{{ $ActivityName }}
a. <5
b. 5-10
c. 10-20
d. >20
Any other
a. <1%
b. 1-5%
c. 5-10%
d. >10%
a. Yes
b. No
a. Always
b. Often
c. Sometimes
d. Rarely
a. By documenting delayed gastric emptying
b. By excluding gastric outlet obstruction
c. On the basis of history and clinical examination
d. Any other
a. Gastroesophageal (GE) scintigraphy
b. Stable-isotope GE breath testing
c. Wireless motility capsule (WMC)
d. Functional ultrasonography
a. <10%
b. 10-20%
c. 20-30%
d. 30-40%
e. >40%
a. No barrier
b. Majority of patients are asymptomatic
c. Lack of reliable diagnostic tests
d. Awareness among physicians
e. Any other
a. Strongly agree
b. Agree
c. Neutral
d. Disagree
e. Strongly disagree
c. Depends on patient profile
a. < 2 weeks
b. 2-4 weeks
c. 4-8 weeks
d. > 8 weeks
e. Any other, Mention Details
a. Efficacy of agent
b. Adverse effect profile
c. Prior experience with prokinetic agent
d. Any other, Mention Details
a. All patients
b. Patients having multiple co-morbidities
c. Patients having cardiovascular disease
d. Patients taking multiple drugs
a. Within 1-week
b. Within 2 weeks
c. Within 3 weeks
d. Within 4 weeks
a. <5%
b. 5-10%
c. 10-15%
d. 15-20%
e. >20%